[SYRE] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- -139.17%
YoY- -5.02%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 1,373 859 1,585 1,073 3,427 0 0 -
PBT -5,430 -4,547 -3,987 -3,413 -1,427 -2,468 -3,181 42.87%
Tax 0 0 0 0 0 0 0 -
NP -5,430 -4,547 -3,987 -3,413 -1,427 -2,468 -3,181 42.87%
Tax Rate - - - - - - - -
Total Cost 6,803 5,406 5,572 4,486 4,854 2,468 3,181 66.07%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -395.48 -529.34 -251.55 -318.08 -41.64 0.00 0.00 -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -11.53 -9.95 0.00 -12.51 -5.23 -9.88 0.00 -
EPS Diluted -11.53 -9.95 0.00 -12.51 -5.23 -9.88 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.